Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Piramal Pharma LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:543635NSE Symbol: PPLPHARMAP/E(TTM):52.15
ISIN Demat:INE0DK501011Div & Yield %:0EPS(TTM):2.96
Book Value(Rs):50.7356863Market Cap ( Cr.):20419.7Face Value(Rs):10
    Change Company 
( In Cr)
 Mar 2023Mar 2022Mar 2021
INCOME :   
Sales Turnover 3443.223340.422938.81
Excise Duty0.000.000.00
Net Sales3443.223340.422938.81
Other Income 341.07224.79216.20
Stock Adjustments -53.3132.66-57.86
Total Income3730.983597.873097.15
EXPENDITURE :   
Raw Materials 1715.171594.171169.91
Power & Fuel Cost107.9483.8368.08
Employee Cost 548.50448.03395.15
Other Manufacturing Expenses 359.64299.83252.74
Selling and Administration Expenses 499.95427.82258.75
Miscellaneous Expenses 68.1459.20117.39
Less: Pre-operative Expenses Capitalised0.000.000.00
Total Expenditure3299.342912.882262.02
Operating Profit431.64684.99835.13
Interest 115.8757.294.71
Gross Profit315.77627.70830.42
Depreciation192.08165.37143.64
Profit Before Tax123.69462.33686.78
Tax38.77110.82104.98
Fringe Benefit tax0.000.000.00
Deferred Tax15.42-16.0310.30
Reported Net Profit69.50367.54571.50
Extraordinary Items -3.14-10.6415.44
Adjusted Net Profit72.64378.18556.06
Adjst. below Net Profit -2.5931.70-2.46
P & L Balance brought forward918.28569.040.00
Statutory Appropriations 0.000.000.00
Appropriations 13.4050.000.00
P & L Balance carried down971.79918.28569.04
Dividend0.000.000.00
Preference Dividend0.000.000.00
Equity Dividend %0.005.600.00
Earnings Per Share-Unit Curr0.583.105.75
Earnings Per Share(Adj)-Unit Curr0.57NANA
Book Value-Unit Curr44.0943.2041.23